Completed
Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
NCT05292872
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholestasis, +9 more
- Locations
-
- Intercept Pharmaceuticals, Inc San Diego, California, United States